Group items tagged

Completed study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the patients with mild reflux oesophagitis.

The Hydrocephalus Association provides support, education and advocacy for people whose lives have been touched by hydrocephalus and the professionals who work with them. We strive to ensure that families are empowered with educational materials, informed about the latest research, and have access to quality health care. We advocate for increased research and funding to advance understanding, improve diagnosis and treatment, and find a cure.

The Guardians of Hydrocephalus Research Foundation (GHRF) was established in 1977 as a non-profit organization. Since then we have distributed over 10,000 information packets and received many phone calls every month answering important questions from concerned parents and worried individuals. Provides information to the public without cost so that a better understanding of hydrocephalus will be established. Provide counseling to families with children who have hydrocephalus to define specific problems that parents encounter and help resolve them as best as possible. We make many referrals to our doctors (more on page 3) who can assist individuals and their families through these tough times.

The Clinical Center is home to the National Institutes of Health intramural clinical research program. Located on the NIH Bethesda, Maryland campus, the Clinical Center complex is where clinical biomedical research occurs.

The relation between eye movement and brain function is a subject of interest to the National Eye Institute. By comparing eye movement in healthy volunteers to research conducted on patients who have difficulty moving their eyes, the National Eye Institute hopes to develop and improve diagnostic procedures for people with eye diseases. Objectives: To study eye movement in 100 healthy adult and child volunteers. To understand how individuals see visual patterns and how eye movement affects the ability to see.

As the lead Federal agency charged with supporting and conducting health services research, the Agency for Health Care Policy and Research (AHCPR) has undertaken and funded important studies in many areas of long-term care research. The bibliographies tlisted provide citations for selected findings as well as a complete listing of long-term care research conducted and funded by AHCPR since 1990

Completed study sponsored by the UNiversity of Aarhus to evaluate the effect of performing a periacetabular osteotomy on patients with hip dysplasia.

Future planned study sponsored by Ullevaal University Hospital to find out whether 4 different protein sources affect the rate of gastric emptying and electrofysiology in study group of children

Study is to determine the predictive values and prognostic accuracies of CSF dynamic measures, the TAP -TEST (high-volume cerebrospinal fluid withdrawal), resistance to CSF outflow and compliance in the prediction of shunt-treatment outcome in patients with idiopathic normal pressure hydrocephalus.

Stanford University completed study on the relationship between spasticity and strength in children with cerebral palsy and reducing spasticity permits and increase in strength

Study being sponsored by the University of New Mexico. Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk for low bone density

Compare the percent of subjects with moderate/severe esophagitis who achieve complete endoscopic resolution after 8 weeks of treatment morning vs. bedtime

The National Hydrocephalus Foundation (NHF) was incorporated in the state of Illinois in 1979 as a voluntary, not-for-profit, 501 C (3), public service organization. The objectives of NHF are: To assemble and disseminate information pertaining to hydrocephalus, its treatments and outcomes To establish and facilitate a communication network among affected families and individuals To help others gain a deeper understanding of those areas affected by hydrocephalus, such as education, insurance, tax and estate planning, employment and family To increase public awareness and knowledge of hydrocephalus To promote and support research on the causes, treatment and prevention of hydrocephalus

Effect of treatment on the movement disorder will be measured by a myoclonus scale and a dystonia scale as well as by assessment of overall functional status. Response at various dosages will be compared to baseline for all patients.Safety parameters including neurological examination, blood tests and EKG will be monitored throughout the treatment period and during withdrawal of the medication.